HAE : Analysis & Opinions

  1. Haemonetics Corporation (HAE): New Analyst Report from Zacks ...

    December 18, 2014
    Haemonetics reported a disappointing second quarter fiscal 2015 with adjusted EPS of $0.47, which although surpassed the ...
  2. MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

    May 1, 2014
    MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
  3. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  4. Edwards' Sapien XT Now in Japan - Analyst Blog

    June 25, 2013
    Edwards receives regulatory approval for Sapien XT in Japan.
  5. Pall's Growth Doesn't Support The Valuation

    June 8, 2012
    Pall's mediocre growth doesn't justify a premium valuation.
Trading Center